AA
Antipodean Advisors’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.48M | Hold |
1,000,000
| – | – | 7.58% | 4 |
|
|
2023
Q2 | $1.61M | Hold |
1,000,000
| – | – | 11.42% | 4 |
|
|
2023
Q1 | $2.9M | Hold |
1,000,000
| – | – | 17.94% | 3 |
|
|
2022
Q4 | $3.28M | Hold |
1,000,000
| – | – | 10.95% | 3 |
|
|
2022
Q3 | $3.78M | Hold |
1,000,000
| – | – | 9.67% | 4 |
|
|
2022
Q2 | $7.79M | Hold |
1,000,000
| – | – | 12.69% | 4 |
|
|
2022
Q1 | $9.29M | Hold |
1,000,000
| – | – | 6.73% | 4 |
|
|
2021
Q4 | $15.8M | Sell |
1,000,000
-50,000
| -5% | -$788K | 6.47% | 4 |
|
|
2021
Q3 | $18.8M | Buy |
1,050,000
+50,000
| +5% | +$895K | 5.32% | 5 |
|
|
2021
Q2 | $15.6M | Hold |
1,000,000
| – | – | 4.28% | 5 |
|
|
2021
Q1 | $14.4M | Hold |
1,000,000
| – | – | 4.44% | 5 |
|
|
2020
Q4 | $19.6M | Hold |
1,000,000
| – | – | 5.51% | 5 |
|
|
2020
Q3 | $13M | Buy |
1,000,000
+200,000
| +25% | +$2.59M | 4.74% | 6 |
|
|
2020
Q2 | $11.7M | Buy |
800,000
+579,000
| +262% | +$8.44M | 5.38% | 7 |
|
|
2020
Q1 | $1.88M | Buy |
+221,000
| New | +$1.88M | 1.74% | 7 |
|